Display Settings:

Format

Send to:

Choose Destination

    Crit Care. 2004 Apr;8(2):93-5. Epub 2004 Jan 22.

    Is there a place for N-acetylcysteine in the treatment of septic shock?

    Del Sorbo L, Zhang H.

    Department of Anaesthesia and Department of Critical Care Medicine, St Michael's Hospital, University of Toronto, Ontario, Canada.

    Comment on:

    Excessive inflammatory responses and impaired oxygen utilization because of microcirculatory failure are implicated in septic shock. Recent studies have pointed out some beneficial effects in the treatment of septic shock of several vasodilators that exert anti-inflammatory properties. In particular, the antioxidant N-acetylcysteine has been demonstrated to enhance cardiac performance, and to improve hepatosplanchnic perfusion and liver function in patients with established septic shock. These clinical observations may lead us to examine further the role of antioxidant agents in developing novel therapies for septic shock.

    PMID: 15025765 [PubMed - indexed for MEDLINE]

    PMCID: 420026

    Supplemental Content

    Click here to read Click here to read